BMS Archive

Plant · Scientific monograph

Artemisia annua

Sweet wormwood / Qinghao

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Allergic rhinitis research, Antimalarial research

Research overview

Historical use

Artemisia annua has a history of traditional use in East Asian medicine; WHO describes the plant and its traditional context [2]. Artemisinin medicines are purified or semisynthetic drugs and should not be conflated with whole-plant tea [2,3].

Modern research context

A phase III study examined standardized A. annua pollen drops for seasonal allergic rhinitis. This allergen immunotherapy is distinct from oral herb use. A separate study of Artemisia tea for malaria does not support using it as a substitute for recommended antimalarial treatment [1,3].

Adverse effects

In the pollen-immunotherapy RCT, treatment-related adverse events were common but none was serious [1]. Safety findings from standardized pollen drops do not establish safety of teas, extracts or essential oil.

Contraindications

Do not use whole-plant preparations as a substitute for proven malaria treatment [2,3]. Safety of oral medicinal preparations in pregnancy, lactation and chronic disease is not established in the sources reviewed.

Clinical and phytochemical data

Used part

Aerial parts and leaves are used in traditional preparations; human trials cited here study standardized pollen drops or separate oral preparations, not interchangeable material [1-3].

Primary active compounds

  • Artemisinin (reported constituent; not a proxy for whole-plant clinical effect) [2]

Mechanism of action

The clinical studies cited here do not establish a mechanism for oral A. annua preparations. Allergen-specific SLIT is a distinct immunotherapy and should not be used to infer pharmacology of the whole herb [1].

Pharmacokinetics

Absorption

Human PK data for whole-plant preparations were not identified. Allergen SLIT exposure is not oral-herb PK [1].

Distribution

Not characterized in the human sources reviewed.

Metabolism

No human whole-plant metabolism data identified.

Excretion

No human whole-plant excretion data identified.

Safety and interactions

Drug interactions

No species- and preparation-specific clinical interaction study was identified in the sources reviewed.

Toxicity

The cited human sources do not establish long-term toxicity for whole-plant oral products. Product, plant part and route differ substantially across preparations [1-3].

Special precautions

Pregnancy

Medicinal use during pregnancy has not been established in the cited sources; avoid inferring safety from traditional use.

Lactation

Lactation safety data for medicinal preparations were not identified.

Hepatic impairment

No human data sufficient to characterize hepatic impairment were identified.

Renal impairment

No human data sufficient to characterize renal impairment were identified.

Sources and references

  1. [1] Lou H et al. Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial. World Allergy Organization Journal. 2020;13(9):100458. PMID: 32963688. DOI: 10.1016/j.waojou.2020.100458.
  2. [2] WHO. WHO monographs on selected medicinal plants: Artemisia annua L. WHO; 2009.
  3. [3] Markus S. Mueller et al. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2004;98(5):318–321. PMID: 15109558. DOI: 10.1016/j.trstmh.2003.09.001.

Additional source links

Continue browsing